Israeli Legislation.com
RegulationsHealth

National Health Insurance (Financial Supervision and Control of Health Funds) Regulations, 5766-2006

תקנות ביטוח בריאות ממלכתי (פיקוח ובקרה פיננסית על קופות החולים), תשס"ו-2006

Published: 2006-01-19Consolidated Hebrew text as of 2023-09-18 · Last amended 2020-05-21
Premium
Unofficial English translation — for reference only. It may contain errors or omissions and cannot be relied on as a legal text. Only the Hebrew text published in Reshumot is legally binding.More

This English text was translated from the official Hebrew using a range of translation tools, and it undergoes ongoing checks and updates. It is not a certified translation.

Despite these checks, it may contain errors, omissions, or imprecise renderings of legal terminology and cross-references, and it may not yet reflect the latest amendments. It cannot be relied upon as a legal text.

The Hebrew text as published in Reshumot (ספר החוקים) and on the Knesset website is the sole authoritative and legally binding version. In any discrepancy, the Hebrew text prevails.

This translation is provided for informational purposes only and does not constitute legal advice. For use in legal proceedings, request a certified Expert Legal Opinion.

Fourth Schedule (regulations 14, 15(c)(5) and 17)

1.§

Health Fund Activity – General

The activity and general development of the health fund, and the corporations related to the fund, shall be described; the description shall be at the "group" level (the fund and the corporations related to the fund), except in cases where material information regarding the fund separately or the related corporations separately does not receive adequate expression in the description of the group; the description shall include, inter alia, the following details:

(1)the year of incorporation of the fund and its form of incorporation;
(2)the institutions of the fund;
(3)the senior office holders of the fund;
(4)structural changes carried out in the fund and their results;
(5)material acquisitions carried out by the fund;
(6)acquisition, sale or disposal of assets on a material scale, not in the ordinary course of the fund's activity;
(7)details of a process of liquidation, receivership and creditors' arrangement carried out in the fund;
(8)any material change that occurred in the management of the fund's affairs.
2.§

Health Fund Activity – Fields of Activity

(a)In this Schedule, "field of activity" – a material economic activity component of a health fund, in which all of the following conditions are met:
(1)it involves expenditure or income for the fund (including expenditure and income related to other activity components of the fund);
(2)its results are reviewed on an ongoing basis by the senior management of the fund, for the purpose of making decisions regarding the allocation of resources to the component, and for the purpose of evaluating the fund's performance in relation to it;
(3)financial information exists in respect thereof.
(b)Without derogating from the generality of the provisions of subsection (a), each of the following shall be regarded as a field of activity of a fund:
(1)services provided by the health fund within the framework of the basic services basket;
(2)operation of hospitals;
(3)additional health services, pursuant to section 10 of the National Health Insurance Law;
(4)dental medicine;
(5)residential institutions, including old age homes and nursing institutions;
(6)convalescent and recuperation homes;
(7)any additional sector that, pursuant to the criteria of Standard 11 of the Israeli Accounting Standards Board, warrants separate segment reporting.
(c)In respect of each field of activity, the report shall include:
(1)a brief description of the field of activity;
(2)the revenues of the field from external customers;
(3)the surplus of activity revenues over operating expenses attributable to the field;
(4)a description of the material details relating to the fund's activity in the field and its results during the years preceding the date of the report, as well as the fund's projected activity in the field and its projected results;
(5)information regarding transfer prices between it and other fields of activity.
(d)A brief description shall be given of trends, events and developments in the fields of activity in which the fund operates, if in the opinion of the council they are material and relevant to the fund's activity and have or are expected to have a material effect on the activity of the health fund in general or on any of its fields of activity; details regarding trends, events, developments and their effect shall not be included if they were included as part of the reporting referred to in item 3 below; without derogating from the generality of the foregoing, the following matters shall be addressed in such reporting, provided they are material:
(1)changes in the structure of the field of activity;
(2)restrictions, legislative arrangements and special constraints in the field of activity from a political or social perspective;
(3)changes in the scope of activity in the field and its results;
(4)developments in the markets of the field of activity or changes in the characteristics of its insured persons;
(5)technological or other changes capable of materially affecting the field of activity;
(6)critical success factors in the field of activity and changes therein;
(7)changes in the supervision framework and raw materials in the field of activity;
(8)changes in the principal barriers to entry and exit in the field of activity;
(9)innovations in the field of substitutes for the products of the field of activity;
(10)changes in the competitive structure within the field of activity;
(11)expectation of the entry of significant competitors into the field of activity or the exit of existing competitors from the field of activity.
3.§

General Environment and the Effect of External Factors on the Fund's Activity

Trends, events and developments in the macro-economic environment in which the fund operates and which have or are expected to have a material effect on its state of affairs shall be described, with an indication of the existing or expected effect, except for trends, events and developments that received full expression in previous reports of the fund; among these, technological and economic developments relevant to the fund, the implications of the security situation on the fund's activity, primary legislation or secondary legislation, and social trends that may affect the fund's activity shall be detailed; the report shall include a quantification or estimate of the effect of the events and developments referred to, if the fund has quantified or estimated such effect.

4.§

New Technologies

Changes in the basket of health services, as well as any material effect that such a change has on the financial position of the fund, shall be detailed.

5.§

Quantitative Data on Insured Persons and Other Needs

The quarterly average of the number of insured persons in the fund and in the additional health services plan, as well as the number of "standardised persons" in the fund during the reporting period, shall be stated.

6.§

Fixed Assets and Installations

A brief description shall be given of the location and general characteristics of the principal real property, every material real property asset, and the other material fixed assets of the fund; material new clinics and installations that came into operation during the year of the report shall be noted. The description required does not constitute a list of addresses and a current specification, but rather a description that will enable the user of the financial reports to better understand the components of the fixed assets and installations in the service production function of the funds. The fields of activity that the described assets serve shall be identified; if material assets are held otherwise than in the fund's ownership or are subject to a material restriction, whether legal or other, this shall be noted and briefly described. The details pursuant to this paragraph are intended to provide information in connection with the type, efficiency and capacity of the fund's resources; a detailed description of the physical characteristics of any property or its legal characteristics is not required.

7.§

Intangible Assets

A review shall be given in respect of: patents, trade marks, licences, concessions and other intellectual property in which the fund holds rights; in respect of the principal intangible assets, their importance to the field of activity, their effect, their useful life and the costs and investments therein shall be detailed.

8.§

Human Capital

The organisational structure, the number of employees employed by the fund according to fields of activity and in accordance with the organisational structure, data regarding the seniority of employees in the fund and their level of education, in a format to be chosen by each fund, material changes that occurred in the employee complement during the period reviewed in the periodic report, dependence on particular employees, the fund's investments in training and instruction, employee remuneration plans, benefits and the nature of the material employment agreements, structural changes, efficiency plans and reductions in the employee complement that have been carried out or are expected or planned to be carried out, shall be described.

9.§

Raw Materials and Suppliers

A concise description of the principal raw materials used in the field of activity (including medicines), their availability, the manner of engagement with principal suppliers, including framework agreements with authorised suppliers and temporary suppliers, as well as details of ethical medicines that have become generic; the fund may report what is required under this section as a general and non-quantitative report.

10.§

Working Capital

The fund's policy in all matters relating to working capital items, including the holding of medicine inventories and credit policy; the average period and average scope during the reporting periods of supplier credit, and the average period and average scope during the reporting period of credit extended by the fund, shall be detailed, all where there is a material difference between them. The calculations may be made on the basis of monthly data.

11.§

Investments

A brief description shall be given of the fund's material investments, including in related companies, ventures, partnerships and other activities; the description shall include the activity of the corporation or venture in respect of which the investment was made.

12.§

Financing

The fund's marginal interest rate in respect of credit shall be detailed, that is, the interest rate fixed for the most recent material loan received, for short-term and long-term separately, and with separation of bank credit sources from non-bank sources. Material developments that occurred in the fund's marginal interest rate in the recent period shall be addressed, with a comparison to changes in the market. Restrictions, internal and external, applicable to the fund in obtaining credit shall be detailed, such as: Government credit permits, a credit limit set by the board of directors, a requirement by lenders regarding a defined financial ratio (covenants), compliance with a business plan, and the need for the financier's consent to certain actions in the fund. Details of the fund's credit facilities and their terms shall be provided, and the balance of credit utilised as at a date as close as possible to the periodic report shall be stated; information regarding charges (security interests) and their terms shall also be provided.

13.§

Legal Restrictions on the Fund's Activity

The legal restrictions or legal arrangements relating to the fund's activity and materially affecting it shall be detailed.

14.§

Material Agreements

A brief description shall be given of the principal terms of material agreements, not in the ordinary course of business, to which the fund is a party or by which it is bound or entitled or on which it is dependent, and which were in force during the two years preceding the date of the report, including employment agreements and agreements with insurance companies. A brief description shall also be given of the principal terms of material strategic cooperation agreements to which the fund is a party or by which it is bound or entitled or on which it is dependent. For this purpose, "cooperation agreement" – including with other health funds within the framework of which services are provided to the insured persons of those health funds.

15.§

Legal Proceedings

(a)Every material pending legal proceeding to which the fund or companies related to it are a party shall be briefly described, as well as every bankruptcy proceeding, receivership or similar material proceeding relating to a company significant to the fund. The results of every such legal proceeding that took place and the date of its conclusion shall be detailed.
(b)Notwithstanding the provisions of sub-item (a) –
(1)routine legal proceedings that are the result of the conduct of the fund's ordinary activity shall be described in a summary description only;
(2)a legal proceeding the principal element of which is a torts claim against the fund or a company related to it shall not be specified in the details to be provided pursuant to sub-item (a), unless the amount claimed, excluding interest and costs, exceeds 20% of the total assets of the health fund and the companies related to it, on a consolidated basis;

however, legal proceedings as aforesaid that raise similar or common legal issues or factual matters, or that are otherwise materially connected to each other, shall be detailed if the amount claimed in all of them together exceeds the said rate.

(c)The description of legal proceedings shall include the court or institution before which the proceedings are pending, the principal parties thereto, the facts that prima facie constitute the cause of action of the proceeding and the relief sought.
(d)Every material proceeding that, to the best of the fund's knowledge, a governmental body or an authority established by law is considering, examining or planning to initiate against the fund or a materially related company of the fund shall be detailed.
(e)Every material proceeding in which any of the senior office holders of the fund, the companies related to the fund and an interested party in the fund or in a company related to it, is an adverse party to the fund or a related company as aforesaid, or has in that proceeding a material interest adverse to the interests of the fund or a company related to it, shall be detailed.
16.§

Objectives and Strategy in the Fund's Activity

The strategy decided upon by the fund for its fields of activity and its principal objectives shall be presented, and the means used by the fund to implement the said strategy and objectives shall be described. The opportunities and threats arising from the fund's strategy shall be detailed. The presentation of the strategy shall include matters such as:

(1)development trends in the fund's activities;
(2)principal projects that the fund is planning or implementing;
(3)geographical distribution;
(4)material entry into new activities and exit from existing activities;
(5)acquisitions, mergers and strategic cooperation;
(6)material expansions and changes in the fund's production capacity and logistical systems;
(7)important research and development projects that are on the verge of maturation or market entry;
(8)important changes in the marketing framework and in the treatment of insured persons;
(9)changes in the organisational structure or legal structure;
(10)material changes in the fund's human resources framework;
(11)construction or development of new capabilities;
(12)significant changes in the capital structure;
(13)other material plans for the future.
17.§

Forecast of Developments in the Coming Year

A general description shall be given of plans that deviate from the ordinary course of operations, which the fund has decided to implement in the coming year, if they may have a material impact on the state of the fund's affairs and the results of its activity with respect to the fields of activity. Disclosure in respect of such a plan shall include, inter alia, projections on matters such as:

(1)material acquisition of fixed assets and the expected production capacity following the acquisition;
(2)material changes in the organisational framework and the employee complement in the various units of the fund;
(3)other matters that may be unique to the fund's activity; if the required information is not available, in whole or in part, the reasons for its unavailability shall be detailed.
18.§

Information regarding a Material Change in the Fund's Expected Operating Results

Information by virtue of which the fund's expected operating results in the near future will differ materially from the operating results reported by the fund in a previous or parallel period, as the case may be, shall be detailed, with an indication of explanations for the expected changes.

19.§

Other Forecasts and Assessments regarding the Fund's Operations and Results

Forward-looking information of any kind that is not expressly required in the sections above may be included, such as the fund's business plan, an analysis of its market trends, and forecasts regarding the results of its operations.

20.§

Discussion of Risk Factors

A brief summary of the threats, weaknesses and other risk factors of the fund arising from its general environment, from the sector and from the unique characteristics of its activity; the discussion shall be concise and clear. In presenting general risks which by their nature apply to all health funds, the particular effect thereof on the fund shall be explained in a clear manner; the risk factors shall be presented in a table according to their nature: macro risks, sector risks, risks specific to the fund, and shall be ranked in categories according to their effect, in the opinion of management, on its operations and results: large, medium and small effect.

Page 2 of 2

Read the entire law on one page — continuous text, no page breaks, plus formal citations.